Medrobotics

Medrobotics Corporation is a privately funded medical device company headquartered in Raynham, Massachusetts that manufactures and markets the Flex Robotic System, the worlds first flexible robotic surgical platform. The Flex Robotic System offers surgeons the unique ability to navigate complex anatomy minimally invasively and operate in hard-to-reach anatomical locations that might otherwise be inaccessible with straight surgical tools. The Company's vision is to provide more patients with access to minimally invasive surgery. Medrobotics received FDA clearance for the Flex Robotic System in July 2015 and the CE mark in March 2014.